STA
ALNY icon

Summit Trail Advisors’s Alnylam Pharmaceuticals ALNY Stock Holding History

Summit Trail Advisors’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.19M Buy
3,598
+84
+2% +$28.6K 0.02% 857
2025
Q4 		$1.4M Buy
3,514
+79
+2% +$35K 0.02% 635
2025
Q3 		$1.57M Buy
3,435
+626
+22% +$255K 0.02% 579
2025
Q2 		$916K Buy
2,809
+1,006
+56% +$278K 0.02% 510
2025
Q1 		$487K Buy
1,803
+518
+40% +$133K 0.02% 256
2024
Q4 		$302K Buy
1,285
+151
+13% +$39.7K 0.01% 289
2024
Q3 		$312K Buy
1,134
+205
+22% +$53.4K 0.01% 533
2024
Q2 		$226K Buy
+929
New +$147K 0.01% 560
2018
Q1 		– Sell
-289
Closed -$39K – 467
2017
Q4 		$39K Buy
+289
New +$36.3K ﹤0.01% 884

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return